Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Bausch & Lomb Corp | Officer | Common Shares, No Par Value | 147K | $2.5M | $17.06 | Mar 1, 2023 | Direct |
Bausch Health Companies Inc. | EVP AND GENERAL COUNSEL | Common Shares, No Par Value | 162K | $1.3M | $8.02 | Mar 10, 2022 | Direct |
Verona Pharma plc | Director | Ordinary Shares | 41.9K | $198K | $4.74 | Nov 6, 2024 | Direct |
CalciMedica, Inc. | Director | Common Stock | 1.43K | $5.29K | $3.70 | Mar 23, 2023 | Direct |
Verona Pharma plc | Director | Share Options (Right to Buy) | 240K | Apr 29, 2024 | Direct | ||
Bausch & Lomb Corp | Officer | Non-Qualified Stock Options (right to purchase) | 90.7K | Mar 1, 2023 | Direct | ||
CalciMedica, Inc. | Director | Restricted Stock Unit | 0 | Mar 23, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VRNA | Verona Pharma plc | Nov 6, 2024 | 1 | $198K | 4 | Nov 7, 2024 | Director |
VRNA | Verona Pharma plc | Apr 29, 2024 | 1 | $0 | 4 | Apr 30, 2024 | Director |
VRNA | Verona Pharma plc | Sep 1, 2023 | 1 | $0 | 4 | Sep 5, 2023 | Director |
VRNA | Verona Pharma plc | Sep 1, 2023 | 0 | $0 | 3 | Sep 5, 2023 | Director |
CALC | CalciMedica, Inc. | Mar 23, 2023 | 2 | $0 | 4 | Mar 27, 2023 | Director |
BLCO | Bausch & Lomb Corp | Mar 1, 2023 | 2 | $1.63M | 4 | Mar 3, 2023 | Officer |
BLCO | Bausch & Lomb Corp | Jul 25, 2022 | 1 | $0 | 4 | Jul 27, 2022 | Officer |
CALC | GRAYBUG VISION, INC. | Jun 2, 2022 | 2 | $0 | 4 | Jun 3, 2022 | Director |
BLCO | Bausch & Lomb Corp | May 5, 2022 | 2 | $0 | 4 | May 9, 2022 | Officer |
BLCO | Bausch & Lomb Corp | May 5, 2022 | 0 | $0 | 3 | May 5, 2022 | Officer |
BHC | Bausch Health Companies Inc. | Mar 10, 2022 | 1 | -$18.9K | 4 | Mar 11, 2022 | EVP AND GENERAL COUNSEL |
BHC | Bausch Health Companies Inc. | Mar 3, 2022 | 1 | -$164K | 4 | Mar 7, 2022 | EVP AND GENERAL COUNSEL |
BHC | Bausch Health Companies Inc. | Feb 26, 2022 | 6 | -$982K | 4 | Mar 2, 2022 | EVP AND GENERAL COUNSEL |
BHC | Bausch Health Companies Inc. | Aug 27, 2021 | 1 | -$145K | 4 | Aug 31, 2021 | EVP AND GENERAL COUNSEL |
CALC | GRAYBUG VISION, INC. | Jun 2, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Director |
BHC | Bausch Health Companies Inc. | Jun 2, 2021 | 5 | -$2.06M | 4 | Jun 4, 2021 | EVP AND GENERAL COUNSEL |